UAMS Awarded $2.2 Million Grant to Investigate Efferocytosis in Retinopathy
The University of Arkansas for Medical Sciences (UAMS) has received a $2.2 million grant from the National Eye Institute (NEI).
Medical Cannabis Use in Children Under 18: Balancing Promise and Research Gaps
Ohio and Kentucky laws permit doctors to recommend medical cannabis for patients under 18, raising questions about its safety and efficacy.
Akston Biosciences and Purdue University Launch Immunotherapy Trial for Canine Bladder Cancer
Purdue University and Akston Biosciences are trialing an anti-cPD-L1 monoclonal antibody to treat canine urothelial carcinoma.
AI Analysis Reveals Persistent Exclusion of Pregnant Individuals in Clinical Trials
AI analysis of over 40,000 clinical trials reveals that less than 1% include pregnant participants, highlighting a critical gap in medical research.
PharmAla to Supply University of Texas, San Antonio, with Novel MDMA Dosage Form for Clinical Trial
PharmAla Biotech has been contracted to supply LaNeo™ MDMA to the University of Texas, San Antonio, for a clinical trial.
University of Colorado Cancer Center Partners with Flatiron Health to Streamline Clinical Trial Data Management
Flatiron Health and University of Colorado Cancer Center launch collaboration to implement Clinical Pipe™, an advanced EHR-to-EDC connector that streamlines clinical trial data capture.
University of Sydney Secures $8.3 Million for Innovative Clinical Trials in Cancer and Addiction Treatment
The National Health and Medical Research Council (NHMRC) has awarded $8.3 million to University of Sydney researchers for clinical trials addressing critical gaps in cancer and addiction treatment.
University of Wollongong Secures $500K Grant to Advance ResectAssist™ Cancer Device for Pancreatic Tumors
University of Wollongong researchers received $500,000 from Australian Economic Accelerate Ignite Grants to develop ResectAssist™, a biodegradable implantable device for inoperable pancreatic cancer.
Ibrutinib Delays Disease Progression in Early-Stage CLL, but No Survival Benefit Observed
A phase III trial (CLL12) found that ibrutinib significantly prolonged the time to symptomatic disease in patients with early-stage chronic lymphocytic leukemia (CLL) compared to placebo.
Pitt Scientists Validate Blood Test for Early Alzheimer's Diagnosis via 100+ Biomarkers
Researchers at the University of Pittsburgh have validated a blood test that measures over 100 genetic sequences linked to Alzheimer's disease, potentially replacing spinal taps.
Stem Cell-Derived Therapy Trial Enrolls First Michigan Patient for Drug-Resistant Epilepsy
Wayne State University enrolled the first Michigan patient in a Phase I/II trial testing stem cell-derived interneuron implantation to reduce seizure frequency.
University of Hong Kong to Enhance AI Tool for Cardiovascular Disease Risk Prediction
The University of Hong Kong (HKU) is launching a recruitment round for its "Heartwise" study, aiming to enroll 3,000 patients.
University of Michigan's Rogel Center Bolsters Pancreatic Cancer Research with $50 Million Gift
The University of Michigan's Rogel Cancer Center receives a $50 million gift to enhance pancreatic cancer research, accelerating translational studies and clinical trials.
Lenacapavir Shows Promise as HIV Prophylactic but Affordability Remains a Key Hurdle
Lenacapavir, an antiretroviral drug, has demonstrated near 100% effectiveness in preventing HIV infections with twice-yearly injections, offering a more discreet and convenient option compared to daily oral medications.
Liv Hospital Partners with University of Pennsylvania to Establish Local CAR-T Cell Manufacturing in Turkey
Liv Hospital and Istinye University have signed a comprehensive collaboration with the University of Pennsylvania's Perelman School of Medicine to develop CAR-T cell therapy and proton therapy capabilities in Turkey.
Aga Khan University Hospital Launches Clinical Trial of KRAS Inhibitor GDC-6036 in Kenya
A new clinical trial in Kenya is evaluating Roche's GDC-6036, a novel drug targeting the KRAS gene, in cancer patients.
Novel BrioVAD Heart Pump Begins Clinical Trial at University of Michigan, Challenging HeartMate 3's Market Dominance
University of Michigan researchers have initiated the INNOVATE trial to test BrioVAD, a new mechanical heart pump that could provide an alternative to the currently dominant HeartMate 3 device for end-stage heart failure patients.
University of Hyderabad and Krismo Biosciences Partner to Develop Novel Therapies for Inflammatory Diseases and Viral Infections
The University of Hyderabad (UoH) and Krismo Biosciences have formed a strategic partnership to develop next-generation therapies targeting inflammatory diseases and serious infectious conditions including Dengue, COVID-19, and Influenza.
First Clinical Trial of DM199 Launched to Combat Preeclampsia
Stellenbosch University initiates a clinical trial for DM199, a novel drug targeting the root cause of preeclampsia, a severe pregnancy complication.
FDA Clears IND for Myogenica's MyoPAXon in Duchenne Muscular Dystrophy
Myogenica, a University of Minnesota startup, received FDA clearance for its IND application for MyoPAXon, a stem cell therapy for muscular regeneration.